Wednesday, September 16, 2026Latest filing Sep 14, 2026

Seth Magaziner Periodic Transaction Report

Filed Jul 2, 2024 · House Clerk · 1 transaction

U.S. Representative · D · RI-02 · All trades by Seth Magaziner

On July 2, 2024, Rep. Seth Magaziner (D-RI-02) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated May 31, 2024.

None of the reported assets carry a stock ticker (bonds, funds, or private holdings).

Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 32 days.

1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.

Source document: House Clerk filing 20025372

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Seth Magaziner · Bought · May 31 · $15K–$50K

0.33LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.50
Cluster activityx 0.150.00
Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Seth Magaziner

Get an email the moment Seth Magaziner files the next one. Free, no card, no spam.

Follow free →
1
Transactions
1 / 0
Buys / sells
0
Tickers
32d
Longest lag

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
May 31, 2024Galileo, Inc. [PS]buySpouse$15K–$50K32d

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →